Plain-English translation of NCT06755762 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing a new approach to personalize cancer treatment by growing cancer cells from your blood in the laboratory and testing them against different drugs. The goal is to figure out which drug will work best for your specific cancer before you start treatment. This could help doctors choose the most effective therapy for you from the start.
Many people with head and neck cancer don't respond well to standard treatments, and doctors currently have no way to predict which drug will work best for each patient. This study aims to fill that gap by using blood tests to match patients with the treatment most likely to help them survive longer.
You likely qualify if…
You likely don't qualify if…
If you have cancer, you will donate blood samples so researchers can grow your cancer cells in the lab and test different drugs against them to see which works best. Healthy volunteers will also provide blood samples to serve as a comparison group. The study involves blood draws and following the trial procedures as outlined by the research team.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Taiwan
Enrollment target
~88 participants
Started
August 2024
Primary completion
July 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Chia-Hsun Hsieh, PhD
Division of Oncology, Chang Gung Memorial Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.